A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia （ITP）

Clinical trial NCT02203422 · WITHDRAWN

Trial details

NCT number: NCT02203422
Sponsor: Shandong University
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Immune Thrombocytopenia

Start date: 2014-07-01
Primary completion: 2015-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.